The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Lineage dependency and lineage-survival oncogenes in human cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760
Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
MicroRNA expression profiles classify human cancers
Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,539
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368
Self-citationThe language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
DNA methylation patterns and epigenetic memory
Bird, A. (2002) · Genes & Development · doi:10.1101/gad.947102 · Cited by 7,124
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
Demetri, G. D., von Mehren, M., Blanke, C. D., Van den Abbeele, A. D., Eisenberg, B., Roberts, P. J., Heinrich, M. C., Tuveson, D. A., Singer, S., Janicek, M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020461 · Cited by 4,389
Tumour stem cells and drug resistance
Dean, M., Fojo, T., & Bates, S. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1590 · Cited by 3,668
Multiclass cancer diagnosis using tumor gene expression signatures
Ramaswamy, S., Tamayo, P., Rifkin, R., Mukherjee, S., Yeang, C.-H., Angelo, M., Ladd, C., Reich, M., Latulippe, E., Mesirov, J. P., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211566398 · Cited by 2,023
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
Kantarjian, H., Sawyers, C., Hochhaus, A., Guilhot, F., Schiffer, C., Gambacorti-Passerini, C., Niederwieser, D., Resta, D., Capdeville, R., Zoellner, U., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011573 · Cited by 2,019
Fraga, M. F., Ballestar, E., Villar-Garea, A., Boix-Chornet, M., Espada, J., Schotta, G., Bonaldi, T., Haydon, C., Ropero, S., Petrie, K., et al. (2005) · Nature Genetics · doi:10.1038/ng1531 · Cited by 1,923
Androgen Receptor in Prostate Cancer
Heinlein, C. A., & Chang, C. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0032 · Cited by 1,780
Addiction to Oncogenes--the Achilles Heal of Cancer
Weinstein, I. B. (2002) · Science · doi:10.1126/science.1073096 · Cited by 1,728
AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian Cancer
Anzick, S. L., Kononen, J., Walker, R. L., Azorsa, D. O., Tanner, M. M., Guan, X.-Y., Sauter, G., Kallioniemi, O.-P., Trent, J. M., & Meltzer, P. S. (1997) · Science · doi:10.1126/science.277.5328.965 · Cited by 1,639
Cairncross, J. G., Ueki, K., Zlatescu, M. C., Lisle, D. K., Finkelstein, D. M., Hammond, R. R., Silver, J. S., Stark, P. C., Macdonald, D. R., Ino, Y., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.19.1473 · Cited by 1,610
Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer
Versteege, I., Sévenet, N., Lange, J., Rousseau-Merck, M.-F., Ambros, P., Handgretinger, R., Aurias, A., & Delattre, O. (1998) · Nature · doi:10.1038/28212 · Cited by 1,556
Garraway, L. A., Widlund, H. R., Rubin, M. A., Getz, G., Berger, A. J., Ramaswamy, S., Beroukhim, R., Milner, D. A., Granter, S. R., Du, J., et al. (2005) · Nature · doi:10.1038/nature03664 · Cited by 1,548
Self-citationEpithelial-Mesenchymal Transitions
Kang, Y., & Massagué, J. (2004) · Cell · doi:10.1016/j.cell.2004.07.011 · Cited by 1,525
The Concept of Synthetic Lethality in the Context of Anticancer Therapy
Kaelin, W. G. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1691 · Cited by 1,379
Functional domains of the human estrogen receptor
Kumar, V., Green, S., Stack, G., Berry, M., Jin, J.-R., & Chambon, P. (1987) · Cell · doi:10.1016/0092-8674(87)90581-2 · Cited by 1,316
Epigenetic Regulation of Cellular Memory by the Polycomb and Trithorax Group Proteins
Ringrose, L., & Paro, R. (2004) · Annual Review of Genetics · doi:10.1146/annurev.genet.38.072902.091907 · Cited by 1,077
All-trans-Retinoic Acid in Acute Promyelocytic Leukemia
Tallman, M. S., Andersen, J. W., Schiffer, C. A., Appelbaum, F. R., Feusner, J. H., Ogden, A., Shepherd, L., Willman, C., Bloomfield, C. D., Rowe, J. M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710093371501 · Cited by 1,073
Cyclin D1 provides a link between development and oncogenesis in the retina and breast
Sicinski, P., Donaher, J. L., Parker, S. B., Li, T., Fazeli, A., Gardner, H., Haslam, S. Z., Bronson, R. T., Elledge, S. J., & Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90034-9 · Cited by 1,021
Rules for Making Human Tumor Cells
Hahn, W. C., & Weinberg, R. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmra021902 · Cited by 951
The role of FLT3 in haematopoietic malignancies
Stirewalt, D. L., & Radich, J. P. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1169 · Cited by 865
Wong, A. J., Bigner, S. H., Bigner, D. D., Kinzler, K. W., Hamilton, S. R., & Vogelstein, B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.19.6899 · Cited by 849
Principles for the Buffering of Genetic Variation
Hartman IV, J. L. (2001) · Science · doi:10.1126/science.291.5506.1001 · Cited by 808
Principles for the buffering of genetic variation
Hartman, J. L., Garvik, B., & Hartwell, L. (2001) · Science · doi:10.1126/science.1056072 · Cited by 808
McGill, G. G., Horstmann, M., Widlund, H. R., Du, J., Motyckova, G., Nishimura, E. K., Lin, Y.-L., Ramaswamy, S., Avery, W., Ding, H.-F., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00762-6 · Cited by 760
The retinoblastoma tumour suppressor in development and cancer
Classon, M., & Harlow, E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc950 · Cited by 738
The molecular basis of lung morphogenesis
Warburton, D., Schwarz, M., Tefft, D., Flores-Delgado, G., Anderson, K. D., & Cardoso, W. V. (2000) · Mechanisms of Development · doi:10.1016/s0925-4773(99)00325-1 · Cited by 729
ATP-Dependent Chromatin-Remodeling Complexes
Vignali, M., Hassan, A. H., Neely, K. E., & Workman, J. L. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.6.1899-1910.2000 · Cited by 729
Mice lacking cyclin D1 are small and show defects in eye and mammary gland development.
Fantl, V, Stamp, G., Andrews, A., Rosewell, I., & Dickson, C. (1995) · Genes & Development · doi:10.1101/gad.9.19.2364 · Cited by 691
Genetic predisposition to colorectal cancer
de la Chapelle, A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1453 · Cited by 661
MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes
Hemesath, T. J., Price, E. R., Takemoto, C., Badalian, T., & Fisher, D. E. (1998) · Nature · doi:10.1038/34681 · Cited by 630
Deregulated homeobox gene expression in cancer: cause or consequence?
Abate-Shen, C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc907 · Cited by 617
Cancer stem cells: lessons from leukemia
Wang, J. C. Y., & Dick, J. E. (2005) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.07.004 · Cited by 615
Chromatin disruption and modification
Wolffe, A. P., & Hayes, J. J. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.3.711 · Cited by 553
Zhao, X., Li, C., Paez, J. G., Chin, K., Jänne, P. A., Chen, T.-H., Girard, L., Minna, J., Christiani, D., Leo, C., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3308 · Cited by 543
Self-citationRedundant cyclin overexpression and gene amplification in breast cancer cells.
Keyomarsi, K., & Pardee, A. B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.3.1112 · Cited by 512
Mitf from neural crest to melanoma: signal transduction and transcription in the melanocyte lineage
Goding, C. R. (2000) · Genes & Development · doi:10.1101/gad.14.14.1712 · Cited by 471
The melanocyte differentiation program predisposes to metastasis after neoplastic transformation
Gupta, P. B., Kuperwasser, C., Brunet, J.-P., Ramaswamy, S., Kuo, W.-L., Gray, J. W., Naber, S. P., & Weinberg, R. A. (2005) · Nature Genetics · doi:10.1038/ng1634 · Cited by 439
Du, J., Widlund, H. R., Horstmann, M. A., Ramaswamy, S., Ross, K., Huber, W. E., Nishimura, E. K., Golub, T. R., & Fisher, D. E. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.10.014 · Cited by 421
Omholt, K., Platz, A., Kanter, L., Ringborg, U. K., & Hansson, J. (2003) · PubMed · Cited by 399
Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression
Carreira, S., Goodall, J., Aksan, I., La Rocca, S. A., Galibert, M.-D., Denat, L., Larue, L., & Goding, C. R. (2005) · Nature · doi:10.1038/nature03269 · Cited by 395
Widlund, H. R., & Fisher, D. E. (2003) · Oncogene · doi:10.1038/sj.onc.1206443 · Cited by 371
Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer.
Tanner, M., Grénman, S., Koul, A., Johannsson, O. T., Meltzer, P. S., Pejovic, T. B., Borg, Å., & Isola, J. J. (2000) · PubMed · Cited by 370
Zhao, X., Weir, B. A., LaFramboise, T., Lin, M., Beroukhim, R., Garraway, L., Beheshti, J., Lee, J. C., Naoki, K., Richards, W. G., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4603 · Cited by 337
Self-citationThe pathophysiology of HOX genes and their role in cancer
Grier, D., Thompson, A., Kwasniewska, A., McGonigle, G., Halliday, H., & Lappin, T. (2005) · The Journal of Pathology · doi:10.1002/path.1710 · Cited by 308
Spectrum of hSNF5IINI1 Somatic Mutations in Human Cancer and Genotype-Phenotype Correlations
Sevenet, N., Lellouch-Tubiana, A., Schofield, D., Hoang-Xuan, K., Gessler, M., Birnbaum, D., Jeanpierre, C., Jouvet, A., & Delattre, O. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.13.2359 · Cited by 305
The genetics of malignant melanoma: lessons from mouse and man
Chin, L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1145 · Cited by 302
Loercher, A. E., Tank, E. M. H., Delston, R. B., & Harbour, J. W. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200410115 · Cited by 266
The INK4a/ARF locus and melanoma
Sharpless, N. E., & Chin, L. (2003) · Oncogene · doi:10.1038/sj.onc.1206461 · Cited by 261
Kulesa, P. M., Kasemeier-Kulesa, J. C., Teddy, J. M., Margaryan, N. V., Seftor, E. A., Seftor, R. E. B., & Hendrix, M. J. C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506977103 · Cited by 243
Antisense therapy in oncology: new hope for an old idea?
Tamm, I., Dörken, B., & Hartmann, G. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05629-x · Cited by 229
Gilliland, D. G., & Griffin, J. D. (2002) · Current Opinion in Hematology · doi:10.1097/00062752-200207000-00003 · Cited by 202
The Cdx-1 and Cdx-2 homeobox genes in the intestine
Freund, J.-N., Domon-Dell, C., Kedinger, M., & Duluc, I. (1998) · Biochemistry and Cell Biology · doi:10.1139/o99-001 · Cited by 189
Development of melanocyte precursors from the vertebrate neural crest
Dupin, E., & Le Douarin, N. M. (2003) · Oncogene · doi:10.1038/sj.onc.1206460 · Cited by 188
Thyroid transcription factor 1 in pulmonary adenocarcinoma
Stenhouse, G., Fyfe, N., King, G., Chapman, A., & Kerr, K. M. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.007138 · Cited by 181
Androgen-Induced Differentiation and Tumorigenicity of Human Prostate Epithelial Cells
Berger, R., Febbo, P. G., Majumder, P. K., Zhao, J. J., Mukherjee, S., Signoretti, S., Campbell, K. T., Sellers, W. R., Roberts, T. M., Loda, M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2938 · Cited by 177
Self-citationKho, A. T., Zhao, Q., Cai, Z., Butte, A. J., Kim, J. Y. H., Pomeroy, S. L., Rowitch, D. H., & Kohane, I. S. (2004) · Genes & Development · doi:10.1101/gad.1182504 · Cited by 163
Establishing Genetic Interactions by a Synthetic Dosage Lethality Phenotype
Kroll, E. S., Hyland, K. M., Hieter, P., & Li, J. J. (1996) · Genetics · doi:10.1093/genetics/143.1.95 · Cited by 162
Morris, M. J., Tong, W. P., Cordon‐Cardo, C., Drobnjak, M., Kelly, W. K., Slovin, S. F., Terry, K. L., Siedlecki, K. L., Swanson, P. M., Rafi, M., et al. (2002) · PubMed · Cited by 161
Inferring Loss-of-Heterozygosity from Unpaired Tumors Using High-Density Oligonucleotide SNP Arrays
Beroukhim, R., Lin, M., Park, Y., Hao, K., Zhao, X., Garraway, L. A., Fox, E. A., Hochberg, E. P., Mellinghoff, I. K., Hofer, M. D., et al. (2006) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0020041 · Cited by 158
Self-citationChromatin remodeling in development and differentiation
Müller, C., & Leutz, A. (2001) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00175-1 · Cited by 151
Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas
REIFENBERGER, J., Knobbe-Thomsen, C. B., Sterzinger, A. A., Blaschke, B., Schulte, K. W., Ruzicka, T., & Reifenberger, G. (2004) · International Journal of Cancer · doi:10.1002/ijc.11722 · Cited by 146
Thyroid transcription factor-1
Bingle, C. D. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(97)00007-1 · Cited by 146
Bringuier, P., Tamimi, Y., Schuuring, E. M. D., & Schalken, J. A. (1996) · PubMed · Cited by 139
Stem cells in the etiology and treatment of cancer
Zhang, M., & Rosen, J. M. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2005.12.008 · Cited by 137
Using high-throughput SNP technologies to study cancer
Engle, L. J., Simpson, C. L., & Landers, J. E. (2006) · Oncogene · doi:10.1038/sj.onc.1209368 · Cited by 130
Dukers, D. F., van Galen, J. C., Giroth, C., Jansen, P. M., Sewalt, R. G. A. B., Otte, A. P., Kluin‐Nelemans, H. C., Meijer, C. J. L. M., & Raaphorst, F. M. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63175-6 · Cited by 125
Salti, G. I., Manougian, T., Farolan, M. J., Shilkaitis, A. L., Majumdar, D., & Gupta, T. K. D. (2000) · PubMed · Cited by 120
Reissmann, P. T., Koga, H., Figlin, R. A., Holmes, E. C., & Slamon, D. J. (1999) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s004320050243 · Cited by 118
How to become neural crest: From segregation to delamination
Morales, A. V., Barbas, J. A., & Nieto, M. A. (2005) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2005.06.003 · Cited by 117
Both products of the mouse Ink4a/Arf locus suppress melanoma formation in vivo
Sharpless, N. E., Kannan, K., Xu, J., Bosenberg, M., & Chin, L. (2003) · Oncogene · doi:10.1038/sj.onc.1206809 · Cited by 116
Finding the next Gleevec: FLT3 targeted kinase inhibitor therapy for acute myeloid leukemia
Sawyers, C. L. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00080-6 · Cited by 110
Frequent deletion of hSNF5/INI1, a component of the SWI/SNF complex, in chronic myeloid leukemia.
Grand, F., Kulkarni, S., Chase, A., Goldman, J. M., Gordon, M. Y., & Cross, N. C. P. (1999) · PubMed · Cited by 108
Chromatin Remodeling and Cancer
Davis, P. K., & Brachmann, R. K. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.189 · Cited by 108
Oncogenomics and the development of new cancer therapies
Strausberg, R. L., Simpson, A. J. G., Old, L. J., & Riggins, G. J. (2004) · Nature · doi:10.1038/nature02627 · Cited by 97
Transcription factors that regulate growth and differentiation of myeloid cells.
Nagamura-Inoue, T., Tamura, T., & Ozato, K. (2001) · International Reviews of Immunology · doi:10.3109/08830180109056724 · Cited by 94
Identifying and characterizing a novel activating mutation of the FLT3 tyrosine kinase in AML
Jiang, J., Paez, J. G., Lee, J. C., Bo, R., Stone, R. M., DeAngelo, D. J., Galinsky, I. A., Wolpin, B. M., Jonasova, A. T., Herman, P. K., et al. (2004) · Blood · doi:10.1182/blood-2004-02-0712 · Cited by 90
Self-citationWaltregny, D., Leav, I., Signoretti, S., Soung, P., Lin, D. I., Merk, F. B., Adams, J. Y., Bhattacharya, N., Cirenei, N., & Loda, M. F. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.5.0640 · Cited by 88
Steroid receptors in human breast cancer
Clarke, R. B., Anderson, E., & Howell, A. (2004) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2004.07.004 · Cited by 85
BMI-1 Is Highly Expressed in M0-Subtype Acute Myeloid Leukemia
Sawa, M., Yamamoto, K., Yokozawa, T., Kiyoi, H., Hishida, A., Kajiguchi, T., Seto, M., Kohno, A., Kitamura, K., Itoh, Y., et al. (2005) · International Journal of Hematology · doi:10.1532/ijh97.05013 · Cited by 81
Positional information and pattern formation in development
Wolpert, L. (1994) · Developmental Genetics · doi:10.1002/dvg.1020150607 · Cited by 80
Choosing anticancer drug targets in the postgenomic era
Kaelin, W. G. (1999) · Journal of Clinical Investigation · doi:10.1172/jci8888 · Cited by 79
Tissue, cell and stage specificity of (epi)mutations in cancers
Sieber, O. M., Tomlinson, S. R., & Tomlinson, I. P. M. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1674 · Cited by 77
Bcl-2 antisense oligonucleotides: a potential novel strategy for the treatment of breast cancer
Nahta, R. (2003) · Seminars in Oncology · doi:10.1053/j.seminoncol.2003.08.016 · Cited by 77
Weber, B. L. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00026-0 · Cited by 54
Differentiation Therapy for Acute Promyelocytic Leukemia
Fenaux, P., & Degos, L. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710093371509 · Cited by 45
Soubeyran, P., Haglund, K., Garcia, S., Barth, B. U., Iovanna, J., & Đikić, I. (2001) · Oncogene · doi:10.1038/sj.onc.1204551 · Cited by 43
"Lineage Addiction" in Human Cancer: Lessons from Integrated GenomicsPreprint
Garraway, L. A., Weir, B. A., ZHAO, X., Widlund, H. R., Beroukhim, R., Berger, A. J., Rimm, D. L., Rubin, M. A., Fisher, D. E., Meyerson, M. M., et al. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.016 · Cited by 41
Self-citationBirtle, A. J., Freeman, A., Masters, J. R., Payne, H. A., Harland, S. J., & Contributors to the BAUS Section of Oncology Cancer Registry (2003) · Cancer · doi:10.1002/cncr.11821 · Cited by 32
Berman, J. J. (2005) · BMC Cancer · doi:10.1186/1471-2407-5-100 · Cited by 28
From Integrated Genomics to Tumor Lineage Dependency
Garraway, L. A., & Sellers, W. R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4604 · Cited by 28
Self-citationThe Reciprocal Dance between Cancer and Development
Chodosh, L. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmcibr020712 · Cited by 26
Development of Serotonin Antagonists for the Control of Chemotherapy‐Induced Emesis
Hainsworth, J. D. (1993) · Seminars in Surgical Oncology · doi:10.1002/j.1098-2388.1993.tb00021.x · Cited by 19
A panorama of lineage‐specific transcription in hematopoiesis
Kluger, Y., Lian, Z., Zhang, X., Newburger, P. E., & Weissman, S. M. (2004) · BioEssays · doi:10.1002/bies.20144 · Cited by 18
Nishi, T., & Saya, H. (1991) · Cancer and Metastasis Reviews · doi:10.1007/bf00554792 · Cited by 15
Array-based approaches to cancer genome analysis
Garraway, L. A., & Sellers, W. R. (2005) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2005.05.020 · Cited by 6
Self-citation
Cited by
Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
Lovén, J., Hoke, H. A., Lin, C. Y., Lau, A., Orlando, D. A., Vakoc, C. R., Bradner, J. E., Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.03.036 · Cited by 2,961
The Mutational Landscape of Head and Neck Squamous Cell Carcinoma
Stransky, N., Egloff, A. M., Tward, A. D., Kostic, A. D., Cibulskis, K., Sivachenko, A., Kryukov, G. V., Lawrence, M. S., Sougnez, C., McKenna, A., et al. (2011) · Science · doi:10.1126/science.1208130 · Cited by 2,504
Self-citationDrugging the undruggable RAS: Mission Possible?
Cox, A. D., Fesik, S. W., Kimmelman, A. C., Luo, J., & Der, C. J. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4389 · Cited by 1,997
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
Lu, G., Middleton, R. E., Sun, H., Naniong, M., Ott, C. J., Mitsiades, C. S., Wong, K.-K., Bradner, J. E., & Kaelin, W. G. (2014) · Science · doi:10.1126/science.1244917 · Cited by 1,583
Visvader, J. E. (2011) · Nature · doi:10.1038/nature09781 · Cited by 1,449
Metadata
- Authors
- Garraway, L. A., & Sellers, W. R.
- Venue
- Nature Reviews Cancer
- Published
- 2006-08-01
- Volume
- 6
- Issue
- 8
- Pages
- 593-602
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2028368645
- Cited by
- 360
- References
- 102
- FWCI
- 0.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.